Huons Global Co., Ltd. (KOSDAQ:084110)

South Korea flag South Korea · Delayed Price · Currency is KRW
63,200
+200 (0.32%)
At close: Feb 27, 2026
Market Cap771.23B +84.6%
Revenue (ttm)825.44B +1.8%
Net Income24.39B -33.2%
EPS1,999.54 -33.0%
Shares Out12.20M
PE Ratio31.61
Forward PEn/a
Dividend880.00 (1.39%)
Ex-Dividend DateApr 2, 2026
Volume55,747
Average Volume51,460
Open62,300
Previous Close63,000
Day's Range60,300 - 63,200
52-Week Range31,500 - 66,000
Beta1.04
RSI76.20
Earnings DateFeb 13, 2026

About Huons Global

Huons Global Co., Ltd. manufactures and sells pharmaceutical products for human health in South Korea and internationally. The company offers oral solid form products in the areas of circulatory system, metabolic, anti-pyretic analgesic anti-inflammatory, musculoskeletal system, digestive system, antihistamine, respiratory system, antibiotic, well-being, urogenital system, other chemotherapeutic, and others; and injections in the areas of anesthetic, antipyretic, analgesic, anti-inflammatory, skeletal muscle relaxant, antispasmodic, antihistami... [Read more]

Sector Healthcare
Founded 1965
Employees 118
Stock Exchange KOSDAQ
Ticker Symbol 084110
Full Company Profile

Financial Performance

In 2024, Huons Global's revenue was 813.46 billion, an increase of 7.26% compared to the previous year's 758.38 billion. Earnings were 25.79 billion, a decrease of -32.81%.

Financial Statements